Industry Focus

Latest Episodes:

Healthcare: How Many Stocks Should You Own in Your Portfolio? Nov 22, 2017

Show notes

You know the market is risky and you shouldn't own just one or two stocks, but you're probably wondering how many stocks you should own. In today's episode, we dig into diversification to help you build a better portfolio.

CG: Over $100 Billion of Entertainment Assets on the Chopping Block Nov 21, 2017

Show notes

While AT&T and Time Warner investors prepare themselves for a tough legal battle with the Justice Department to close their merger, competitors are circling the valuable media empire that could be going up for sale at Twenty-First Century Fox.

Financials: Tax Reform: What It Could Mean to You Nov 20, 2017

Show notes

Financials looks at the two tax reform bills currently making their way through Congress, the differences between them, and the likely winners and losers of tax reform.

Tech: What's Behind Roku's Double? Nov 17, 2017

Show notes

Roku's first report as a publicly traded company couldn't have gone better. With a second look at their books, are we more sold on the long-term viability of the streaming company?

Editor's note: In the show, we mistakenly said that 1/3 of Roku's platform revenue comes from licensing. That 1/3 portion of the platform revenue is actually from content distribution, the licensing portion is much smaller.

Thanks to Harry’s for supporting Motley Fool. Harry’s will give you their trial shave set for FREE when you sign up at Harrys.com/FOOL - just pay for shipping!

Energy: Fracking the Market for Natural Gas Finds Nov 16, 2017

Show notes

The U.S is increasingly being powered by cheap natural gas and the deployment of pipeline infrastructure is ensuring this remains the case for years to come. In this show we discuss why the commodity is growing in popularity, the billions of dollars being spent transporting it across the country, and investment opportunities in the industry.

Healthcare: Why This $6 Billion Biotech Stock Is Skyrocketing 70% in November Nov 15, 2017

Show notes

A flurry of news has investors clamoring to add Nektar Therapeutics to their portfolios. Plus, we explain why investors are disappointed by Loxo Oncology’s good news and how a new smart pill could change medicine forever.

CG: Mattel and Buffalo Wild Wings Flying High Nov 14, 2017

Show notes

Shares of the #2 toy company and casual dining chain are both up double digits thanks to buyout rumors. For Mattel, the potential deal with Hasbro would create a dominant player in the toy industry. Meanwhile, a private equity firm with significant restaurant experience is courting B-Dubs. The team also takes a look at Canada Goose, one of the best-performing IPOs of the year.

Thanks to Harry’s for supporting The Motley Fool. Get your Free Trial Set -- go to Harrys.com/fool.

Financials: Robo-Advisors: What They Mean for Investors and Financial Advisors Nov 13, 2017

Show notes

Financials looks at robo-advisors, the automated substitute for financial advisors that has surged in popularity.

Tech: Snap's Ephemeral Market Cap Nov 10, 2017

Show notes

After missing on revenue, earnings, and users, shares of Snap got pummeled following the company's Q3 earnings release. We work through the release, talk about the company's transition to auction-based ad sales, and check in on the Spectacles hardware segment.

Energy: How Boring Utilities Can Offer Exciting Returns Nov 09, 2017

Show notes

Utilities have historically been classified as safe and boring but the industry is changing and there are some potentially exciting opportunities in the often overlooked segment.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected